Robert L. Grossman: Lawyer with Greenberg Traurig, LLP

Robert L. Grossman

Co-Chair, Israel Practice
Miami,  FL  U.S.A.
Phone305.579.0756

Peer Rating
 5.0/5.0
AV® Preeminent

Client Rating

Featured AV Peer Review Rated Lawyer IconFeatured AV Peer Review Rated Lawyer Icon
Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials Ratings & Reviews
 

Practice Areas

  • Securities, M&A, and Corporate
  • Life Sciences & Medical Technology
  • Health & FDA Business
  • Technology, Media & Telecommunications
  • Mergers & Acquisitions
  • Emerging Technology
 
Contact InfoTelephone: 305.579.0756
Fax: 305-961-5756
http://www.gtlaw.com/People/Robert-L-Grossman
 
University The Ohio State University, B.A., 1975 Recipient, Esteemed Senior Award; The Ohio State University, M.A., 1979 Recipient, Ohio State University Fellow
 
Law SchoolThe Ohio State University Moritz College of Law, J.D., with honors, 1978 Order of the Coif
 
Admitted1978, Ohio; 1982, Florida
 
BornCleveland, Ohio, December 20, 1954
 
Biography

Bob Grossman began practicing securities, M&A and corporate law in the firm's Miami office in 1982. With wide-ranging experience taking companies public, acquiring and selling companies, and as a business advisor, Bob brings a practical business-oriented approach to his clients' problems, focusing on accomplishing his clients' objectives effectively and efficiently. He has represented a diverse collection of public and private companies, including companies in the medical device, pharmaceutical, biotechnology, health care, energy and natural resources, technology and software, and communications industries.

Bob is the Co-Chair of the firm's Israel Practice and is a frequent business visitor to Israel. In addition to representing Israeli companies, the firm's Israel Practice Group provides assistance to Israeli and U.S. companies through introductions to strategic partners. Greenberg Traurig's broad client base and network of offices and other resources are significant components of this process.

Areas of Concentration

bull; Public offerings

bull; Other diverse industry representations

bull; Israeli businesses

Professional & Community Involvement

bull; Member, Greater Miami Jewish Federation, Yerucham Development Committee, 2007-Present
- Board Member, Board of Directors and Executive Committee
- Chairman, Agency, Day School and Synagogue Campaign, 2003-2005
- Past Chairman, South Dade Branch

bull; Board Member, Project Interchange, Board of Directors, 2005-Present

bull; Board Member, Jewish National Fund, Board of Directors, 2005-Present

bull; Board Member, Children's Bereavement Center, Board of Directors, 2001-Present

bull; Board Member, Temple Beth Am, Board of Directors, 2003-2005

bull; Chairman, Executive Institute of Organization for Leadership Advancement in Miami, 2001-2003

bull; Chairman, South Dade Israel Task Force (formed first Victims of Terror in Israel Fund and developed South Dade Israel Awareness Week), 2001-2003

bull; Member, Florida Bar, Corporate Law Subcommittee, 1995-1997

bull; Member, American Bar Association

bull; Member, Dade County Bar Association

bull; Past Chairman and Co-Founder, South Dade Jewish Leadership Council

bull; Past Chairman, National UJA Young Leadership Cabinet, Miami Division

bull; Past Member, Dave and Mary Alper Jewish Community Center, Board of Directors and Executive Committee

bull; Past Member, The Beacon Council, Executive Committee

Awards & Recognition

bull; Listed, South Florida Legal Guide, "South Florida's Top Lawyers," 2007-2014

bull; Listed, Chambers Global, Corporate/M&A, 2011-2014

bull; Listed, Martindale-Hubbell and ALM, "2013 Top Rated Lawyer" - Securities Law, 2013

bull; Team Member, Corporate Board Member magazine and FTI Consulting Inc., one of "America's Best Corporate Law Firms," 13th Annual Legal Industry Study, 2013

bull; Listed, Chambers & Partners USA Guide, "Top Corporate/M&A Lawyer in Florida," 2006-2008, 2013

bull; Member, team ranked as a top corporate law firm in Miami as selected by corporate directors, in the annual "Legal Industry Research Study" by Corporate Board Member magazine and FTI Consulting Inc. (10th year), 2002-2009, 2011-2012

bull; Finalist, Daily Business Review, "Top Dealmaker of the Year - Corporate (Domestic) Category," 2012

bull; Recommended, PLC Which Lawyer? Yearbook, 2009

bull; Listed, Super Lawyers magazine, Florida Super Lawyers, 2006

bull; Listed, Daily Business Review, "South Florida's Top Dealmakers of the Year in Mergers & Acquisitions," 2005

bull; Recipient, "Put Something Back Corporate Award," Eleventh Judicial Circuit and Dade County Bar Association, 2003

bull; Recipient, Greater Miami Jewish Federation
- "Stanley C. Myers Presidents' Leadership Award," 1999
- "Robert Russell Leadership Award," 1998

bull; Listed, South Florida Business Review, "Most Effective Lawyers"

bull; Rated, AV Preeminent® 5.0 out of 5

Professional Experience

Significant Representations

bull; Represented Orbimed Israel in registered direct investment in BiolineRx, Ltd.

bull; Represented Orbimed Israel in PIPE investment in Red Hill BioPharma Ltd.

bull; Representing Galmed Pharmaceuticals, Ltd. in initial public offering.

bull; Represented Prolor Biotech, Inc. in its acquisition by OpKo Health, Inc.

bull; Represented Castle Brands, Inc. in an ATM offering.

bull; Represented Glasses Off, Inc. in a reverse merger and private placement pursuant to which the Company went public.

bull; Represented OpKo Health, Inc. in an investment in RXI Pharmaceuticals and the transfer of certain technology and sale of certain assets to RXI.

bull; Represented Israeli pharmaceutical company Immune Pharmaceuticals Ltd. in a reverse triangular merger with EpiCept Corporation, a U.S. and Swedish publicly traded biopharmaceutical company, whereby Immune became a wholly owned subsidiary of, and Immune's shareholders obtained a controlling interest in, EpiCept, which is now known as Immune Pharmaceuticals Inc.

bull; Represented Prolor Biotech, Inc. in a public offering.

bull; Represented a mobile virtual network operator (MVNO), a subsidiary of a public company, with its approximately $120 million acquisition of substantially all of the assets and assumption of certain of the liabilities of another MVNO that provides prepaid SIM cards to its customers.

bull; Represented Integrity Applications, Inc. in two private placements and becoming a publicly reporting company.

bull; Represented an Israeli pharmaceutical company in listing Level II ADRs.

bull; Represented Castle Brands, Inc., developer and international marketer of premium and super premium alcoholic beverage brands, in a private placement (PIPE) of convertible preferred stock and warrants to various investors, including the conversion of various tranches of the issuer's existing debt into preferred stock.

bull; Represented Nervomatrix, Ltd., an Israeli medical device company, in connection with an investment by an Ohio private equity/venture capital fund.

bull; Represented the representative of the shareholders of Beeologics in its sale of all the stock of Beeologics Holdings Limited, a Cyprus entity, and Beeologics, Inc., a BVI entity, to Monsanto Company.

bull; Represented OPKO Health, Inc. (NYSE: OPK) in connection with its acquisition of Claros Diagnostics, Inc. a private company engaged in the development and marketing of medical diagnostic devices.

bull; Represented Ladenburg Thalmann Financial Services, Inc. in its acquisition of Securities America and its subsidiaries.

bull; Represented IVAX Corporation in its merger with TEVA Pharmaceutical Industries Ltd.

bull; Represented Frost Group in investment in Protalix and in the transaction by which Protalix became a public company.

bull; Represents various life science companies in private placement, license and distribution agreements and corporate transactions and matters.

bull; Represents various life science companies in private placement, license and distribution agreements and corporate transactions and matters.

bull; Represents Opko Health Inc., Ladenburg Thalmann & Co Inc., Castle Brands, Inc., Non-Invasive Monitoring System Inc., Integrity Applications, Inc., Glasses Off, Inc. and other companies as outside securities counsel.

bull; Represented UBS in a public offering of Protalix Ltd.

bull; Represented Devcon International Corp. in its acquisition of Adelphia electronic security services assets.

bull; Represented Orthodontix, Inc. and The Frost Group in a reverse merger with and investment into Protalix Ltd. pursuant to which Protalix became a publicly reporting company.

bull; Represented various underwriters in public offerings, including public offerings of Israeli companies.

Publications & Presentations

Articles, Lectures & Publications

Articles

bull; Mentioned, "Cleveland Clinic Attracts Israeli Companies with its Smart Money," Medical Device Daily, July 1, 2010

bull; Quoted, "Greenberg Traurig Israel Network Paying Off," Jerusalem Post, July 2, 2006

bull; Mentioned, Two Articles Covering the 3rd Annual Life Sciences Mission to Israel, Globes, June 29, 2006

bull; Mentioned, "American and Canadian Institutional Investors, Managing Over $1 Trillion, to Participate in the Annual High-Tech and Venture Capital Conference of the Israel Venture Association (IVA)," Forbes.com, May 25, 2006

bull; Featured, "Marathon Talks Sealed Sale of Drug-Maker IVAX," Daily Business Review, February 23, 2006

bull; Announcement, Put Something Back Corporate Award, Sun-Sentinel, June 20, 2003

bull; Announcement, Put Something Back Corporate Award, Florida Newspaper, June 18, 2003

bull; Quoted, "Rules, Economy Challenge the Bottom Line This Year," The South Florida Business Journal, Week of January 6, 2003

bull; Quoted, "Bankruptcies, Fraud Scandal Hit Region," The South Florida Business Journal, Week of December 30, 2002

bull; Quoted, "Law Firm Reaches Out to Startups in Israel," Miami Daily Business Review, November 19, 2002

Lectures

bull; Lecturer, "Recent Growth in Transactions in the Israeli Market with a Focus on Life Science and Agriculture - Reasons and Issues," College of Management Academic Studies (COMAS), April 2014

bull; Panelist, The Agrivest Conference, The Eretz Israel Museum, Tel Aviv, Israel, December 3, 2013

bull; Panel Moderator, "What is the IPO Process?" BDO, Greenberg Traurig and Marsh IPO Readiness Seminar, Hollywood, FL, May 25, 2010

bull; Panel Moderator, "Common Texas/Israel Water Opportunities in the 21st Century," Texas-Israel Cleanovation Event, Austin, TX, February 22, 2010

bull; Panelist, WATEC Israel, Tel Aviv Exhibit Center, Tel Aviv, Israel, November 17-19, 2009

bull; Panel Moderator, "How to Add Value Beyond Governance," Florida Chapter of The National Association of Corporate Directors (NACD), Fort Lauderdale, FL, March 6, 2008

bull; Panelist, "Going Public-The Process, the Legal Aspects, the Various Alternatives," The Israeli Association of Publicly Traded Companies, The Semi-Annual Financial Conference, Tel Aviv, Israel, November 8, 2006

bull; Panel Moderator, "The 'EXIT' Path (Mergers & Acquisitions)," Hi-Tech and Venture Capital Conference, Israel Venture Association (IVA), Tel Aviv, Israel, June 20, 2006

bull; Panelist, "Cross Border M&As," The Israel Bar Association's Annual Meeting, Eilat, Israel, May 23, 2006

bull; Panelist, "Exit Strategies for Biotech Companies," International Biotechnology Conference, The Scripps/Oxford, Palm Beach, FL, November 13-15, 2005

bull; Panelist, "Israeli VCs- Bridging Capital and Opportunities," Hi-Tech Venture Capital Conference, Israel Venture Association (IVA), Santa Clara, CA, November 10, 2005

bull; Panel Moderator, "U.S. Capital Market Opportunities for Israeli Companies," 2nd Annual Life Sciences Mission to Israel, Jerusalem, Israel, June 30, 2005

bull; Panel Moderator, "Building the Community: Economic and Non-Economic Indicators," Scripps/Oxford International Biotechnology Conference, Palm Beach, FL, November 15, 2005

bull; Speaker, "Selected Laws and Regulations Affecting Public Companies," Session on U.S. PATRIOT Act and Anti-Money Laundering Procedures: Protecting Your Franchise, 3rd Annual Bear Stearns Central American/Caribbean Conference, Biscayne, FL, September 26, 2003

Published Articles

07.01.08, Latin American M&A Spotlight

Associated News & Events

Press-Releases

05.21.14, 13 Greenberg Traurig Attorneys Recognized By Daily Business Review During Its 2014 Top Dealmakers Of The Year Awards Ceremony

05.16.14, Greenberg Traurig is Lead Sponsor for The MIXiii Israel Innovation Conference

04.11.14, Eight Greenberg Traurig Attorneys In Florida Recognized in 2014 Chambers Global Guide

03.18.14, Greenberg Traurig Attorneys, Practices Worldwide Recognized by Prestigious Chambers Global Guide

03.15.13, 32 Greenberg Traurig Attorneys and 16 Practice Areas Recognized in 2013 Edition of Chambers and Partners Global Guide

11.20.12, 20 Greenberg Traurig Attorneys and 9 Practice Areas Recognized in 2012 Chambers Global Guide

05.31.12, Greenberg Traurig Listed as a Top Corporate Firm for the 10th Time in Corporate Board Member magazine

05.07.12, 18 Greenberg Traurig Attorneys Recognized by Daily Business Review During its 2012 Top Dealmakers of the Year Awards

12.26.11, Thirty-five Greenberg Traurig Attorneys Named 'Top Lawyers' by South Florida Legal Guide

12.06.11, Global Law Firm Greenberg Traurig to Open Office in Israel Next Month

 
Reported CasesRepresented Orbimed Israel in registered direct investment in BiolineRx, Ltd.; Represented Orbimed Israel in PIPE investment in Red Hill BioPharma Ltd.; Representing Galmed Pharmaceuticals, Ltd. in initial public offering.; Represented Prolor Biotech, Inc. in its acquisition by OpKo Health, Inc.; Represented Castle Brands, Inc. in an ATM offering.; Represented Glasses Off, Inc. in a reverse merger and private placement pursuant to which the Company went public.; Represented OpKo Health, Inc. in an investment in RXI Pharmaceuticals and the transfer of certain technology and sale of certain assets to RXI.; Represented Israeli pharmaceutical company Immune Pharmaceuticals Ltd. in a reverse triangular merger with EpiCept Corporation, a U.S. and Swedish publicly traded biopharmaceutical company, whereby Immune became a wholly owned subsidiary of, and Immune's shareholders obtained a controlling interest in, EpiCept, which is now known as Immune Pharmaceuticals Inc.; Represented Prolor Biotech, Inc. in a public offering.; Represented a mobile virtual network operator (MVNO), a subsidiary of a public company, with its approximately $120 million acquisition of substantially all of the assets and assumption of certain of the liabilities of another MVNO that provides prepaid SIM cards to its customers.; Represented Integrity Applications, Inc. in two private placements and becoming a publicly reporting company.; Represented an Israeli pharmaceutical company in listing Level II ADRs.; Represented Castle Brands, Inc., developer and international marketer of premium and super premium alcoholic beverage brands, in a private placement (PIPE) of convertible preferred stock and warrants to various investors, including the conversion of various tranches of the issuer's existing debt into preferred stock.; Represented Nervomatrix, Ltd., an Israeli medical device company, in connection with an investment by an Ohio private equity/venture capital fund.; Represented the representative of the shareholders of Beeologics in its sale of all the stock of Beeologics Holdings Limited, a Cyprus entity, and Beeologics, Inc., a BVI entity, to Monsanto Company.; Represented OPKO Health, Inc. (NYSE: OPK) in connection with its acquisition of Claros Diagnostics, Inc. a private company engaged in the development and marketing of medical diagnostic devices.; Represented Ladenburg Thalmann Financial Services, Inc. in its acquisition of Securities America and its subsidiaries.; Represented IVAX Corporation in its merger with TEVA Pharmaceutical Industries Ltd.; Represented Frost Group in investment in Protalix and in the transaction by which Protalix became a public company.; Represents various life science companies in private placement, license and distribution agreements and corporate transactions and matters.; Represents various life science companies in private placement, license and distribution agreements and corporate transactions and matters.; Represents Opko Health Inc., Ladenburg Thalmann & Co Inc., Castle Brands, Inc., Non-Invasive Monitoring System Inc., Integrity Applications, Inc., Glasses Off, Inc. and other companies as outside securities counsel.; Represented UBS in a public offering of Protalix Ltd.; Represented Devcon International Corp. in its acquisition of Adelphia electronic security services assets.; Represented Orthodontix, Inc. and The Frost Group in a reverse merger with and investment into Protalix Ltd. pursuant to which Protalix became a publicly reporting company.; Represented various underwriters in public offerings, including public offerings of Israeli companies.
 
ISLN906842698
 


View Ratings & Reviews
Profile Visibility
#90 in weekly profile views out of 9,701 lawyers in Miami, Florida
#10,334 in weekly profile views out of 1,511,893 total lawyers Overall

Office Information

Robert L. Grossman

333 SE 2nd Avenue, Suite 4400
MiamiFL 33131




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now